- Home
- XCH vs ME Comparison
XCH vs ME Comparison
Compare XCH & ME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XCH
- ME
- Stock Information
- Founded
- XCH 2015
- ME 2006
- Country
- XCH China
- ME United States
- Employees
- XCH N/A
- ME N/A
- Industry
- XCH
- ME Precision Instruments
- Sector
- XCH
- ME Health Care
- Exchange
- XCH NYSE
- ME Nasdaq
- Market Cap
- XCH 73.7M
- ME 68.4M
- IPO Year
- XCH 2024
- ME N/A
- Fundamental
- Price
- XCH $1.24
- ME $2.42
- Analyst Decision
- XCH
- ME Hold
- Analyst Count
- XCH 0
- ME 1
- Target Price
- XCH N/A
- ME $9.40
- AVG Volume (30 Days)
- XCH 212.9K
- ME 235.7K
- Earning Date
- XCH 01-01-0001
- ME 01-28-2025
- Dividend Yield
- XCH N/A
- ME N/A
- EPS Growth
- XCH N/A
- ME N/A
- EPS
- XCH N/A
- ME N/A
- Revenue
- XCH $39,071,977.00
- ME $208,775,000.00
- Revenue This Year
- XCH N/A
- ME $22.00
- Revenue Next Year
- XCH N/A
- ME $17.31
- P/E Ratio
- XCH N/A
- ME N/A
- Revenue Growth
- XCH N/A
- ME N/A
- 52 Week Low
- XCH $0.94
- ME $2.42
- 52 Week High
- XCH $30.47
- ME $13.74
- Technical
- Relative Strength Index (RSI)
- XCH N/A
- ME 32.49
- Support Level
- XCH N/A
- ME $2.42
- Resistance Level
- XCH N/A
- ME $2.96
- Average True Range (ATR)
- XCH 0.00
- ME 0.19
- MACD
- XCH 0.00
- ME 0.01
- Stochastic Oscillator
- XCH 0.00
- ME 0.00
About XCH XCHG LIMITED SPONSORED EACH ADS REPRESNTNG 40 CLASS A
XCHG Ltd engaged in designing, manufacturing and selling of Electric Vehicle (EV) chargers and EV charging solutions which include the DC fast chargers named the C6 series and the C7 series, the battery-integrated DC fast chargers which is Net Zero Series (NZS), as well as accompanying services. Its integrated solution combining proprietary charging technology, energy storage technology and accompanying services significantly improves EV charging efficiency and unlocks the value of energy storage and management. Its NZS solution enables fast charging at low power locations or vis-a-vis aged grid infrastructures (which typically are not compatible with fast charging equipment) with no site improvements or grid upgrades needed.
About ME 23andMe Holding Co.
23andMe Holding Co is a consumer-facing healthcare technology company, primarily involved in the sale of direct-to-consumer personal genome services, or PGS, through DNA collection kits shipped via mail. The company provides users access to reports summarizing estimated genetic ancestry breakdown, phenotypic trait reports, and various health predisposition and disease carrier reports. Its segment includes Consumer and Research Services and Therapeutics. The company generates maximum revenue from the Consumer and Research Services segment.